Making a Difference – The Business of Rare Disease Drug Development
Drug development designed to treat rare disease is both a noble cause and a risky business. Rare diseases are typically deadly, debilitating, and devastating for…
Drug development designed to treat rare disease is both a noble cause and a risky business. Rare diseases are typically deadly, debilitating, and devastating for…
How AI is advancing and transforming future cancer medical treatments and how a cure for cancer may be closer than we think. AI is transforming…
While opportunities for continuing education and Pharma-sponsored learning programs are always welcome by healthcare providers (HCPs), it is no secret that traditional HCP education is…
Tackling non-communicable diseases (NCDs) like cardiovascular disease, diabetes, and mental health disorders was a key topic at the European Health Summit this year and will…
Does a future exist where every heartbeat, every spike in blood sugar, every subtle change in body temperature is monitored by a tiny device strapped…
The Department of Health and Human Services (HHS) recently issued a final rule under Section 1557 of the Affordable Care Act (ACA), marking a significant…
Delphine Perridy, Chief Commercial Officer at Envirotainer explores six essential predictions shaping pharmaceutical logistics and cold chain for the year ahead. The pharmaceutical cold chain…
The latest figures show that general practice delivered a record 38.6m appointments in October 2024 (or more than 40m if you include COVID-19 jabs), that’s…
Ahead of his talk at Rewired 2025, Andy Haywood, Group Chief Digital Officer at NHS Humber Health Partnership, shares his insights on how digital transformation…
Missed appointments (Did Not Attend or DNAs) still remain a deep-rooted problem for the NHS with thousands of appointments wasted each year. With over 103…